Vencor, Inc. 10-Q Summary: Quarter Ended March 31, 1995
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1995, for Vencor, Inc., a healthcare company operating hospitals and providing respiratory and subacute care services (Vencare program). The filing includes unaudited condensed consolidated financial statements and management discussion. Note: The input metadata referenced "Ventas, Inc.", but the filing text explicitly identifies the registrant as "Vencor, Inc."
Key Financial Metrics
| Metric | Q1 1995 | Q1 1994 |
|---|---|---|
| Total Net Revenues | $120,431,000 | $86,963,000 |
| Net Income | $9,148,000 | $5,920,000 |
| Diluted EPS | $0.31 | $0.23 |
| Operating Cash Flow | $12,031,000 | $5,969,000 |
| Total Assets | $455,604,000 | $390,372,000 |
| Total Long-Term Debt | $123,889,000 | $141,899,000 |
| Working Capital | $86,625,000 | $65,364,000 |
Material Changes vs. Prior Period
- Revenue Growth: Total net revenues increased 38.5% to $120.4 million, driven by a 13.0% increase in patient days and significant expansion of the Vencare program (revenues up from $5.4M to $19.3M).
- Profitability: Net income rose 54.5% to $9.1 million. Operating expenses increased 36.8%, largely due to higher census and Vencare program costs.
- Capital Structure: The company completed a public offering of 2.2 million shares in February 1995, raising approximately $66.5 million. Proceeds were used to reduce revolving credit debt and fund acquisitions.
- Debt Reduction: Long-term debt decreased by approximately $18 million due to the application of equity proceeds.
- Receivables: Net patient accounts receivable increased 46.5% to $108 million, with days outstanding rising from 77 to 81, attributed to slower payment cycles in the Vencare program.
Outlook, Risks, and Unusual Items
- Hillhaven Merger: On April 23, 1995, Vencor entered a definitive agreement to acquire The Hillhaven Corporation. The deal is structured as a pooling of interests. Vencor expects to assume or refinance Hillhaven's indebtedness of approximately $590 million.
- Expansion Plans: Management plans to purchase or lease 10-12 additional hospitals over the next 2-3 years and secure 200+ new respiratory/subacute care contracts annually.
- Liquidity: The revolving credit facility was increased to $200 million in January 1995. With $8 million outstanding, significant capacity remains for future acquisitions.
- Risks: The merger is subject to regulatory and shareholder approvals. The company faces potential uninsured medical malpractice losses if claims-made policies are not renewed, though management deems current coverage adequate.
Investor Verification Checklist
- Verify the status and regulatory approval timeline for the Hillhaven Corporation merger.
- Monitor the collection trends of accounts receivable, specifically the impact of the Vencare program on cash conversion cycles.
- Confirm the terms of the new credit facility required to refinance Hillhaven's $590 million debt.
- Review the integration costs and revenue synergies associated with the recent facility acquisitions and the Hillhaven deal.